Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology

Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology

Background:. The first phase of this study showed that ART FILLER Universal filler (AFU; FILORGA Laboratories) and ART FILLER Fine lines (AFFL) were non-inferior to JUVÉDERM Ultra 3 (Allergan) and FIRST LINES PureSense (Teoxane), respectively. The clinical benefits of AFU and AFFL on nasolabial fold...

Full description

Bibliographic Details
Main Authors: Patrick Trevidic, MD, Pierre Andre, MD, Laurent Benadiba, MD, Jean-Jacques Deutsch, MD, Olivier Galatoire, MD, Philippe Garcia, MD, Anne Grand-Vincent, MD, Sylvie Boisnic, MD, Catherine Salomon, MD, Ferial Fanian, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2020-12-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003274

Internet

http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003274

Similar Items